Amitriptyline efficacy in decreasing implant-induced foreign body reaction

Area of Science:

• Biomaterials Science
• Immunology
• Pharmacology

Background:

• Amitriptyline (AM) has known anti-inflammatory, anti-angiogenic, and anti-fibrogenic effects.
• The impact of AM on foreign body reaction (FBR) following biomedical material implantation is unknown.

Purpose of the Study:

• To evaluate the effects of AM on the angiogenic and fibrogenic components of implant-induced FBR.
• To determine if AM can attenuate the fibroproliferative response around implanted materials.

Main Methods:

• Sponge disks were implanted subcutaneously in C57BL/6 mice.
• Mice received daily oral administration of AM (5 mg/kg) in two treatment protocols.
• Implants were removed at 7 and 14 days post-implantation for analysis.

Main Results:

• AM did not attenuate angiogenic or fibrogenic parameters in 7-day-old implants.
• AM significantly downregulated angiogenesis and FBR in 14-day-old implants.
• No reduction in giant cell numbers was observed at 7 days.

Conclusions:

• Amitriptyline demonstrates potential in attenuating fibroproliferative processes associated with implant materials.
• AM's ability to downregulate angiogenesis and FBR suggests a role in improving implant functionality.
• Further research is warranted to explore AM's therapeutic potential in managing implant-related adverse reactions.